• Medical Information Documents

  • On Demand Medical Videos

    • Congress Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir
      DTG: Metabolic Data Update

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Clinical Trials Data

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir

      The Use of Tivicay plus Epivir for Treatment-Naïve Adults with HIV-1

      GEMINI-1 and GEMINI-2 Studies
      Michael Aboud, VP, Global Medical Lead, Dolutegravir
      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
    • Dosing

      Tivicay PD: An Option for Children Living with HIV

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Pharmacokinetics

      Tivicay PD: An Option for Children Living with HIV

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director

      Tivicay PD: An Option for Children Living with HIV

      Ana M. Puga, MD, Regional Medical Director
    • Safety

      Post-CROI 2021 Webinar

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs

      Post-CROI 2021 Webinar

      Andrew Zolopa, MD, VP, Head, North America Medical Affairs
      DTG: Metabolic Data Update

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      DTG: Metabolic Data Update

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir
      Antiretroviral Therapy and Weight Gain

      Antiretroviral Therapy and Weight Gain

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir

      Antiretroviral Therapy and Weight Gain

      Jean Van Wyk, MBChB, Global Medical Lead, Dolutegravir